Advanced search
Companies (2)
ANNEXIN PHARMACEUTICALS AB
Annexin Pharmaceuticals AB (publ) is a Sweden-based biotechnology company. Its main product is ANXV, a human recombinant protein Annexin A5, for emergency treatment of patients with cardiovascular disease with blood vessel damages and inflammation. ANXV h ...
| Capitalization | 10 M USD |
|---|---|
| Change | -1.92% |
| 1-year price change | +17.69% |
ANNEXIN PHARMACEUTICALS AB (PUBL)
Annexin Pharmaceuticals AB (publ) is a Sweden-based biotechnology company. Its main product is ANXV, a human recombinant protein Annexin A5, for emergency treatment of patients with cardiovascular disease with blood vessel damages and inflammation. ANXV h ...
| Capitalization | 10 M USD |
|---|---|
| Change | -.--% |
| 1-year price change | -.--% |
- Stock Market
- Advanced search
- Mikael Staffas
- Company Profiles